CONTENTS
Yale University
School of Medicine
333 Cedar Street
New Haven, CT
06510 USA(203) 432-1333
Prognosis of Patients with Acute Coronary Syndrome
Despite the use of aspirin, heparin and anti-ischemic therapy, modern clinical trials have documented that the prognosis of patients presenting with an acute coronary syndrome remains poor. Within 4 to 6 weeks of presentation, the risk of death or myocardial infarction is 8% to 14%. (Table 1). The rate of death, MI, or refractory ischemia is even more excessive (approximately 15% to 25%) [1].
Fig. 1. Prognosis of patients with acute coronary syndrome treated with “conventional therapy.”
*Placebo arms (aspirin, heparin monotherapy, and anti-ischemic treatment) of PRISM and PRISM-Plus.
*Approximately 1 out of 10 patients presenting with an acute coronary syndrome will either die or sustain a myocardial infarction within 4 to 6 weeks of presentation.
1. Theroux P., Fuster, V. Acute coronary syndrome. Unstable angina and non-Q-wave myocardial infarction. Circulation 1998; 97:1195-1206.
Last modified: October 14, 1999 (PL)
Copyright ©1999 Yale University School of Medicine. All rights reserved.
Comments or suggestions to the site editor.
Home URL: http://info.med.yale.edu/ysm